Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00031811 · ClinicalTrials.gov registry record · NA
Raloxifene With or Without Exercise Compared With Exercise Alone in Women Who Have Been Previously Treated for Breast Cancer
A NA study, sponsored by OHSU Knight Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT00031811 is a NA study that has completed, run by OHSU Knight Cancer Institute. The registered enrollment target is 80 participants.
The verdict
NCT00031811, a NA study, has completed, sponsored by OHSU Knight Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
RATIONALE: Raloxifene and exercise may improve bone health and quality of life in breast cancer survivors. Assessing bone health and quality of life may improve the ability to plan treatment. PURPOSE: Randomized clinical trial to study the effectiveness of raloxifene with or without exercise compared with exercise alone in women who have been previously treated for breast cancer.
Interventions
- DRUG raloxifene
- PROCEDURE quality-of-life assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2001-03 |
| Est. Completion | 2003-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00031811
The ClinicalTrials.gov registry entry for NCT00031811 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is OHSU Knight Cancer Institute, which has 211 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which raloxifene is the first listed.
NCT00031811 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00031811 about?
NCT00031811 is a clinical study titled "Raloxifene With or Without Exercise Compared With Exercise Alone in Women Who Have Been Previously Treated for Breast Cancer". RATIONALE: Raloxifene and exercise may improve bone health and quality of life in breast cancer survivors. Assessing bone health and quality of life may improve the ability to plan treatment. PURPOSE: Randomized clinical trial to study the effectiveness of raloxifene with or without exercise compar...
What is the current status of trial NCT00031811?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2001-03. Estimated completion is 2003-04.
What interventions are being tested in trial NCT00031811?
The interventions under investigation include: raloxifene (DRUG), quality-of-life assessment (PROCEDURE).
Who is sponsoring clinical trial NCT00031811?
This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.